Quantcast

BBH

Stock Split Image

After the Run-Up and Sell-Off, Are Biotechs in a Bubble Against Big Pharma Valuations?

Posted: May 1, 2013 at 10:45 am

Biotech stocks come and go as far as the flavor of the day for investors. While many of these companies are risky, and while many are too risky for many ...
Read Full Story »
biotech

Daily ETF Folly: Why There Is No True Biotech Representation in ETFs

Posted: March 1, 2013 at 11:10 am

24/7 Wall St. is taking a daily aim at the world exchange-traded funds (ETFs). Many are great, and many are actively traded and truly represent what investors are trying to ...
Read Full Story »
biotech

ETF Folly: Biotech ETFs, Nothing but Confusion

Posted: February 28, 2013 at 12:50 pm

24/7 Wall St. has always wondered about the confusing universe of biotech exchange-traded funds (ETFs). Biotech stocks can rise or fall regardless of the market direction, and the sector performed ...
Read Full Story »

NASDAQ Changes Up Biotech Index Members & Weightings

Posted: May 14, 2012 at 7:59 am

Index changes are generally speaking a fairly routine event.  They can also create underlying moves in the companies added and deleted from them as money management firms often buy and ...
Read Full Story »

Measuring Pre-Earnings Upside in Biotechs (DNDN, HGSI, GILD, AMLN, ARIA, INCY, IBB, XBI, BBH)

Posted: October 19, 2011 at 11:34 am

We have compiled a detailed list of expected upside in the biotech sector.  The sector has consolidated and now there is about to be a rush of earnings reports from ...
Read Full Story »

ETF Watch: Biotechs Fighting M&A Shrinkage (BBH, AMGN, GILD, BIIB, XBI, FBT, CRA, CEPH, IBB)

Posted: April 11, 2011 at 2:01 pm

Biotech is becoming the ever-shrinking stock sector.  It is almost weekly now that a new biotech acquisition is announced.  Big Pharma in the United States and large drugmakers internationally are all interested in ...
Read Full Story »

IPO Watch: The Alternative Genzyme IPO (SNY, GENZ, GCVRZ, BBH, IBB, FBT)

Posted: March 29, 2011 at 1:01 pm

The proposed buyout of Genzyme Corporation (NASDAQ: GENZ) by Sanofi-Aventis (NYSE: SNY) should close this week.  We are about to get a new Genzyme security on the market and that ...
Read Full Story »

Top Investment Trends For Futurists (FFD, AFK, EZA, PHO, PIO, PXN, TINY, LIT, BP, PBW, PZD, PBD, REMX, NLR, MOO, GLD, BBH, IBB, FPX, IPOSX)

Posted: November 19, 2010 at 3:20 pm

Futurists are an odd lot.  Generally, they are authors, scientists,  consultants and economists.  What many people don't know is that investors follow this philosophy as well.  Their goal is to ...
Read Full Story »

Stock Gains Skipping Biotech (GENZ, CELG, GILD, AMGN, BIIB, ALXN, MNKD, HGSI, VVUS, DNDN, BBH, XBI, QQQQ)

Posted: November 6, 2010 at 12:07 pm

Biotech and emerging pharma both seem to have almost no friends today despite a large stock market rally.  It may take a resolution of the Genzyme Corporation (NASDAQ: GENZ) merger, ...
Read Full Story »

BioHealth Business Daily (AGEN, ARRY, GENZ, GILD, HGSI, NPSP, QLTI, RPTP, STEM, BBH, IBB, PBE)

Posted: April 21, 2010 at 2:32 pm

Today's version of the BioHealth Business Daily is rather different as we have a big disappointment from one of the top biotech operations in the world.  BioHealth stocks moving on ...
Read Full Story »

Biotech & BioHealth Business Daily (PFE, MRK, BAX, BDSI, SPPI, GNBT, AVII, CEGE, BBH, GILD, LLY, SNY, BMY, OSIP)

Posted: July 13, 2009 at 10:25 am

Here are some of today's top stories affecting key drug and biotech stocks, accompanied with links through to more detailed information and analysis at BioHealthInvestor.com: New short-interest data suggest traders ...
Read Full Story »

Biotech Movers & Shakers (AMGN, CRME, DNDN, GNVC, DNA, QLTI, TBRN, BBH, XBI)

Posted: March 17, 2008 at 12:30 pm

Biotech’s are sliding along with all the others today. A look at the highlights and outliers:Amgen (NASDAQ: AMGN) and Wyeth (NYSE: WYE) announced that arthritis and psoriasis drug Enbrel will ...
Read Full Story »

Can Genentech Buck Its Long-Term Slide? (DNA, BIIB, NVS, OSIP, AMGN, BBH)

Posted: January 14, 2008 at 12:33 pm

Genentech (NYSE: DNA) is set to report earnings after the close today.  First Call has estimates pegged at $0.67 EPS on revenues of $2.97 Billion.  This will also mark the ...
Read Full Story »

Biotechs and Related Hitting 52-Week Lows Too (BBH, AMGN, AMLN, ARNA, GERN, INGN, PGNX, SUPG)

Posted: January 4, 2008 at 3:22 pm

Today has been a rough day with more 52-week lows than we can recall in quite some time.  The biotechs haven't been immune.  You can even see that the Biotech ...
Read Full Story »